Michèle Teboul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michèle Teboul has a total of 184 co-authors. Here are the top co-authors by number of shared publications:
- Franck Delaunay
Université Côte d’Azur, CNRS, Inserm, iBV
24 shared publications Bruno Claustrat
10 shared publications- Francis Lévi
Research Unit 'Chronotherapy, Cancer, Transplantation', Faculty of Medicine, Paris-Saclay University, Hospital Paul Brousse, Villejuif, France.
9 shared publications Jacques Beau
9 shared publications- Sandrine Dulong
Inserm UMR-S 900, institut curie, université Paris Sciences et Lettres, 92210 Saint-Cloud, France
9 shared publications Sinisa Zampera
9 shared publications
Latest Publications
- Open Access
- 24 November 2023
- Published by Elsevier in Médecine du Sommeil
- Vol. 20 (4) , 249
Couplage et synchronisation d’horloges circadiennes périphériques
- 24 November 2023
- Published by Elsevier in Médecine du Sommeil
- Vol. 20 (4) , 249
Open AccessCouplage et synchronisation d’horloges circadiennes périphériques
- Open Access
- 30 June 2023
- Published by EDP Sciences in médecine/sciences
- Vol. 39 (6-7) , 544-550
Les oscillations harmoniques des rythmes circadiens sortent de l’ombre
Environ 40 % du transcriptome hépatique a une expression circadienne. Récemment, des oscillations harmoniques du rythme circadien, indépendantes de l’horloge circadienne, ont été identifiées. Les transcrits oscillant avec une période de douze heures sont impliqués dans des mécanismes cellulaires fondamentaux et ubiquitaires, tels que la protéostase, le métabolisme des lipides ou le métabolisme des ARN. Un oscillateur ultradien de douze heures impliquant le régulateur de la réponse UPR XBP1, le coactivateur SRC-3 et la protéine des speckles SON, commence à être décrypté. L’oscillateur XBP1 et le transcriptome ultradien de douze heures sont très conservés, suggérant une émergence précoce qui pourrait remonter à une époque où le jour terrestre était bien inférieur à vingt-quatre heures. About 40 % of the liver transcriptome display a circadian expression. Recently, harmonic oscillations of the circadian rhythm and independent of the circadian clock have been identified. Transcripts oscillating with a 12h period are involved in fundamental and ubiquitous cellular mechanisms such as proteostasis, lipid metabolism or RNA metabolism. A 12h ultradian oscillator involving the UPR response regulator XBP1, the coactivator SRC-3 and the speckle protein SON has been uncovered. The XBP1 oscillator and the 12h ultradian transcriptome are highly conserved suggesting an early emergence that may date back to a time when the Earth’s day was much shorter than 24h.
- 30 June 2023
- Published by EDP Sciences in médecine/sciences
- Vol. 39 (6-7) , 544-550
Open AccessLes oscillations harmoniques des rythmes circadiens sortent de l’ombre
Environ 40 % du transcriptome hépatique a une expression circadienne. Récemment, des oscillations harmoniques du rythme circadien, indépendantes de l’horloge circadienne, ont été identifiées. Les transcrits oscillant avec une période de douze heures sont impliqués dans des mécanismes cellulaires fondamentaux et ubiquitaires, tels que la protéostase, le métabolisme des lipides ou le métabolisme des ARN. Un oscillateur ultradien de douze heures impliquant le régulateur de la réponse UPR XBP1, le coactivateur SRC-3 et la protéine des speckles SON, commence à être décrypté. L’oscillateur XBP1 et le transcriptome ultradien de douze heures sont très conservés, suggérant une émergence précoce qui pourrait remonter à une époque où le jour terrestre était bien inférieur à vingt-quatre heures. About 40 % of the liver transcriptome display a circadian expression. Recently, harmonic oscillations of the circadian rhythm and independent of the circadian clock have been identified. Transcripts oscillating with a 12h period are involved in fundamental and ubiquitous cellular mechanisms such as proteostasis, lipid metabolism or RNA metabolism. A 12h ultradian oscillator involving the UPR response regulator XBP1, the coactivator SRC-3 and the speckle protein SON has been uncovered. The XBP1 oscillator and the 12h ultradian transcriptome are highly conserved suggesting an early emergence that may date back to a time when the Earth’s day was much shorter than 24h.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Data from Cancer Inhibition through Circadian Reprogramming of Tumor Transcriptome with Meal Timing
Circadian disruption accelerates cancer progression, whereas circadian reinforcement could halt it. Mice with P03 pancreatic adenocarcinoma (n = 77) were synchronized and fed ad libitum (AL) or with meal timing (MT) from Zeitgeber time (ZT) 2 to ZT6 with normal or fat diet. Tumor gene expression profiling was determined with DNA microarrays at endogenous circadian time (CT) 4 and CT16. Circadian mRNA expression patterns were determined for clock genes Rev-erbα, Per2, and Bmal1, cellular stress genes Hspa8 and Cirbp, and cyclin A2 gene Ccna2 in liver and tumor. The 24-hour patterns in telemetered rest-activity and body temperature and plasma corticosterone and insulin-like growth factor-I (IGF-I) were assessed. We showed that MT inhibited cancer growth by ∼40% as compared with AL (P = 0.011) irrespective of calorie intake. Clock gene transcription remained arrhythmic in tumors irrespective of feeding schedule or diet. Yet, MT upregulated or downregulated the expression of 423 tumor genes, according to CT. Moreover, 36 genes involved in cellular stress, cell cycle, and metabolism were upregulated at one CT and downregulated 12 h apart. MT induced >10-fold circadian expression of Hspa8, Cirbp, and Ccna2 in tumors. Corticosterone or IGF-I patterns played no role in tumor growth inhibition. In contrast, MT consistently doubled the circadian amplitude of body temperature. Peak and trough respectively corresponded to peak expressions of Hspa8 and Cirbp in tumors. The reinforcement of the host circadian timing system with MT induced 24-hour rhythmic expression of critical genes in clock-deficient tumors, which translated into cancer growth inhibition. Targeting circadian clocks represents a novel potential challenge for cancer therapeutics. Cancer Res; 70(8); 3351–60. ©2010 AACR.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Cancer Inhibition through Circadian Reprogramming of Tumor Transcriptome with Meal Timing
Circadian disruption accelerates cancer progression, whereas circadian reinforcement could halt it. Mice with P03 pancreatic adenocarcinoma (n = 77) were synchronized and fed ad libitum (AL) or with meal timing (MT) from Zeitgeber time (ZT) 2 to ZT6 with normal or fat diet. Tumor gene expression profiling was determined with DNA microarrays at endogenous circadian time (CT) 4 and CT16. Circadian mRNA expression patterns were determined for clock genes Rev-erbα, Per2, and Bmal1, cellular stress genes Hspa8 and Cirbp, and cyclin A2 gene Ccna2 in liver and tumor. The 24-hour patterns in telemetered rest-activity and body temperature and plasma corticosterone and insulin-like growth factor-I (IGF-I) were assessed. We showed that MT inhibited cancer growth by ∼40% as compared with AL (P = 0.011) irrespective of calorie intake. Clock gene transcription remained arrhythmic in tumors irrespective of feeding schedule or diet. Yet, MT upregulated or downregulated the expression of 423 tumor genes, according to CT. Moreover, 36 genes involved in cellular stress, cell cycle, and metabolism were upregulated at one CT and downregulated 12 h apart. MT induced >10-fold circadian expression of Hspa8, Cirbp, and Ccna2 in tumors. Corticosterone or IGF-I patterns played no role in tumor growth inhibition. In contrast, MT consistently doubled the circadian amplitude of body temperature. Peak and trough respectively corresponded to peak expressions of Hspa8 and Cirbp in tumors. The reinforcement of the host circadian timing system with MT induced 24-hour rhythmic expression of critical genes in clock-deficient tumors, which translated into cancer growth inhibition. Targeting circadian clocks represents a novel potential challenge for cancer therapeutics. Cancer Res; 70(8); 3351–60. ©2010 AACR.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Data from Cancer Inhibition through Circadian Reprogramming of Tumor Transcriptome with Meal Timing
Circadian disruption accelerates cancer progression, whereas circadian reinforcement could halt it. Mice with P03 pancreatic adenocarcinoma (n = 77) were synchronized and fed ad libitum (AL) or with meal timing (MT) from Zeitgeber time (ZT) 2 to ZT6 with normal or fat diet. Tumor gene expression profiling was determined with DNA microarrays at endogenous circadian time (CT) 4 and CT16. Circadian mRNA expression patterns were determined for clock genes Rev-erbα, Per2, and Bmal1, cellular stress genes Hspa8 and Cirbp, and cyclin A2 gene Ccna2 in liver and tumor. The 24-hour patterns in telemetered rest-activity and body temperature and plasma corticosterone and insulin-like growth factor-I (IGF-I) were assessed. We showed that MT inhibited cancer growth by ∼40% as compared with AL (P = 0.011) irrespective of calorie intake. Clock gene transcription remained arrhythmic in tumors irrespective of feeding schedule or diet. Yet, MT upregulated or downregulated the expression of 423 tumor genes, according to CT. Moreover, 36 genes involved in cellular stress, cell cycle, and metabolism were upregulated at one CT and downregulated 12 h apart. MT induced >10-fold circadian expression of Hspa8, Cirbp, and Ccna2 in tumors. Corticosterone or IGF-I patterns played no role in tumor growth inhibition. In contrast, MT consistently doubled the circadian amplitude of body temperature. Peak and trough respectively corresponded to peak expressions of Hspa8 and Cirbp in tumors. The reinforcement of the host circadian timing system with MT induced 24-hour rhythmic expression of critical genes in clock-deficient tumors, which translated into cancer growth inhibition. Targeting circadian clocks represents a novel potential challenge for cancer therapeutics. Cancer Res; 70(8); 3351–60. ©2010 AACR.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Cancer Inhibition through Circadian Reprogramming of Tumor Transcriptome with Meal Timing
Circadian disruption accelerates cancer progression, whereas circadian reinforcement could halt it. Mice with P03 pancreatic adenocarcinoma (n = 77) were synchronized and fed ad libitum (AL) or with meal timing (MT) from Zeitgeber time (ZT) 2 to ZT6 with normal or fat diet. Tumor gene expression profiling was determined with DNA microarrays at endogenous circadian time (CT) 4 and CT16. Circadian mRNA expression patterns were determined for clock genes Rev-erbα, Per2, and Bmal1, cellular stress genes Hspa8 and Cirbp, and cyclin A2 gene Ccna2 in liver and tumor. The 24-hour patterns in telemetered rest-activity and body temperature and plasma corticosterone and insulin-like growth factor-I (IGF-I) were assessed. We showed that MT inhibited cancer growth by ∼40% as compared with AL (P = 0.011) irrespective of calorie intake. Clock gene transcription remained arrhythmic in tumors irrespective of feeding schedule or diet. Yet, MT upregulated or downregulated the expression of 423 tumor genes, according to CT. Moreover, 36 genes involved in cellular stress, cell cycle, and metabolism were upregulated at one CT and downregulated 12 h apart. MT induced >10-fold circadian expression of Hspa8, Cirbp, and Ccna2 in tumors. Corticosterone or IGF-I patterns played no role in tumor growth inhibition. In contrast, MT consistently doubled the circadian amplitude of body temperature. Peak and trough respectively corresponded to peak expressions of Hspa8 and Cirbp in tumors. The reinforcement of the host circadian timing system with MT induced 24-hour rhythmic expression of critical genes in clock-deficient tumors, which translated into cancer growth inhibition. Targeting circadian clocks represents a novel potential challenge for cancer therapeutics. Cancer Res; 70(8); 3351–60. ©2010 AACR.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Cancer Inhibition through Circadian Reprogramming of Tumor Transcriptome with Meal Timing
Supplementary Figure 2 from Cancer Inhibition through Circadian Reprogramming of Tumor Transcriptome with Meal Timing
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Cancer Inhibition through Circadian Reprogramming of Tumor Transcriptome with Meal Timing
Supplementary Figure 2 from Cancer Inhibition through Circadian Reprogramming of Tumor Transcriptome with Meal Timing